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Matrix Gla Protein and Alkaline Phosphatase Are
Differently Modulated in Human Dermal Fibroblasts
from PXE Patients and Controls
Federica Boraldi1,7, Giulia Annovi1,7, Cees Vermeer2, Leon J. Schurgers3, Tommaso Trenti4,
Roberta Tiozzo5, Deanna Guerra6 and Daniela Quaglino1
Mineralization of elastic fibers in pseudoxanthoma elasticum (PXE) has been associated with low levels of
carboxylated matrix gla protein (MGP), most likely as a consequence of reduced vitamin K (vit K) availability.
Unexpectedly, vit K supplementation does not exert beneficial effects on soft connective tissue mineralization in
the PXE animal model. To understand the effects of vit K supplementation and in the attempt to interfere with
pathways leading to the accumulation of calcium and phosphate within PXE-mineralized soft connective tissues,
we have conducted in vitro studies on dermal fibroblasts isolated from control subjects and from PXE patients.
Cells were cultured in standard conditions and in calcifying medium (CM) in the presence of vit K1 and K2, or
levamisole, an alkaline phosphatase (ALP) inhibitor. Control and PXE fibroblasts were characterized by a similar
dose-dependent uptake of both vit K1 and vit K2, thus promoting a significant increase of total protein
carboxylation in all cell lines. Nevertheless, MGP carboxylation remained much less in PXE fibroblasts.
Interestingly, PXE fibroblasts exhibited a significantly higher ALP activity. Consistently, the mineralization process
induced in vitro by a long-term culture in CM appeared unaffected by vit K, whereas it was abolished by
levamisole.
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INTRODUCTION
Pseudoxanthoma elasticum (PXE) is a genetic disorder asso-
ciated with mutations in the ABCC6 gene (Le Saux et al.,
2000) and characterized by progressive mineralization of
elastic fibers affecting skin, eyes, and the cardiovascular
system (Quaglino et al., 2011). Compared with controls,
fibroblasts from PXE patients exhibit similar in vitro and
in vivo matrix gla protein (MGP) expression, but with a
significant reduction in carboxylated MGP (cMGP; Gheduzzi
et al., 2007), a well-known endogenous inhibitor of soft tissue
calcification (Schurgers et al., 2008). Furthermore, PXE
fibroblasts are characterized by downregulation of protein
disulfide isomerase and upregulation of calumenin, two
proteins of the endoplasmic reticulum (ER) that are involved
in the vitamin K (vit K) cycle (Boraldi et al., 2009). Vit K is a
group of fat-soluble vitamins, which, in their reduced form,
are needed for the posttranslational g-carboxylation of
glutamic acid residues in proteins involved in blood
coagulation and in the mineralization process (Booth, 2009).
Interestingly, the low vit K concentrations measured in the
circulation of PXE patients (Vanakker et al., 2010) were not
associated by an impairment of their blood coagulation
system, indicating that the vitamin can reach the liver to be
metabolized and used for the activation of coagulation factors,
whereas it seems to be extruded or transported less efficiently
from hepatocytes to the periphery (Borst et al., 2008;
Brampton et al., 2011), thus affecting connective tissues. In
this scenario, it has been suggested that vit K supplementation
might be capable of restoring MGP carboxylation and to
inhibit ectopic calcifications (Borst et al., 2008). However,
recent studies in the PXE animal model (ABCC6 / mice)
demonstrated that vit K supplementation does not counteract
the mineralization of soft connective tissues (Brampton et al.,
2011; Gorgels et al., 2011; Jiang et al., 2011). Key question is
whether PXE fibroblasts are able to utilize vit K and restore an
adequate MGP carboxylation.
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As both vit K1 and vit K2 can be used as diet supplements
(Cranenburg et al., 2007), the aim of the present study was to
investigate the effects of vit K1 (phylloquinone) and vit K2
(menaquinone-4, MK-4) supplementation on control and on
PXE dermal fibroblasts, for a better understanding of the role of
vit K–dependent carboxylation of MGP in PXE pathogenesis,
and in the negative outcome of treatments carried out so far in
the animal model.
Moreover, as ectopic calcifications are mainly due to
calcium phosphate precipitation, we also investigated the
possibility to interfere with the mineralization process by
modulating alkaline phosphatase (ALP) activity, which pro-
motes hydroxyapatite formation by acting on phosphate-donor
substrates (Orimo and Shimada, 2008).
RESULTS AND DISCUSSION
Assessment of blood parameters related to ectopic calcification
Calcification is subject to regulation on many different levels,
both systemic and local. We have investigated in 79 PXE
patients the levels of a number of circulating parameters
known to be related to the development of ectopic calcifica-
tions, and compared the values with reference values in
control individuals (Table 1).
Calcemia and phosphatemia are always within normal
range, thus confirming that in PXE (1) deregulation of
circulating levels of calcium and phosphate are only rarely
observed, possibly as an additional unrelated clinical compli-
cation (Mallette and Mechanick, 1987); (2) ectopic
calcification does not take place through the ‘‘calcification
paradox’’ (Krueger et al., 2009), i.e., by increased circulating
levels of calcium and phosphate because of decreased bone
mineral density, as confirmed by the absence of altered bone
metabolism in all patients investigated so far.
Similarly, activity of serum ALP activity never appeared
upregulated in patients (Table 1), which is consistent with the
absence of a generalized calcification process. As collagen
fibrils never undergo mineralization in PXE, and normal as
well as calcified elastic fibers coexist within the same tissues,
it is conceivable to hypothesize a local deregulation of pro-
and anti-calcifyng factors.
Finally, we have measured the levels of dephospho uncar-
boxylated MGP and dephospho carboxylated MGP (Table 1);
no significant differences were observed between control and
PXE samples.
Although it cannot be excluded that altered, nevertheless,
unknown serum factor/s could be present in the circulation of
patients, control subjects and PXE patients, or PXE patients,
with different extent/severity of clinical manifestations cannot
be discriminated on the basis of these parameters.
Vit K uptake by dermal fibroblasts and cell viability
Few data are available in the literature concerning the ability
of fibroblasts to respond to in vitro vit K treatments (Canfield
et al., 1987; Ross et al., 1991), and no data are available on
human dermal fibroblasts in primary culture. In addition, the
demonstration that vit K supplementation does not counteract
soft connective tissue mineralization in the PXE animal model
(Brampton et al., 2011; Gorgels et al., 2011; Jiang et al., 2011)
poses the question whether PXE fibroblasts are unable to
utilize the vitamin (Boraldi et al., 2009).
Despite a certain heterogeneity observed between cells
from different individuals, a similar dose-dependent vit K
uptake is clearly detectable in both control and PXE fibroblasts
(Figure 1), although the uptake of phylloquinone (Figure 1a) is
higher than that of menaquinone (Figure 1b) at comparable
doses in the culture medium. These data clearly demonstrate
that fibroblasts can take up vit K, and that this trait is not
affected by the pathologic phenotype (Figure 1).
In light of these results, further experiments were conducted
with the lowest (0.1mM) and the highest (100mM) vitamin
concentrations. The highest concentration was chosen to
guarantee the possibility to quantify the effects of vitamin
supplementation, even in short-term cultures (48 hours); the
lowest concentration was chosen to follow the intracellular
uptake and to look for eventual cumulative effects in long-
term cultures (X20 days).
Evaluation of cell viability demonstrates that, in standard
culture conditions (i.e., DMEM), both vitamins, even at very
high concentrations and for long-term cultures (420 days),
never appeared to inhibit cell growth or to induce cell death
(data not shown), as demonstrated for K2 in different tumor
cell lines (Ogawa et al., 2007), where the pro-apoptotic effect
of the vitamin could be the consequence of metabolic
pathways associated with the neoplastic phenotype.
Consistently, vit K has been safely used in many long-term
in vivo treatments (Iwamoto et al., 2009), supporting the
feasibility to use these dietary compounds for therapeutic
strategies (McCann and Ames, 2009).
As far as the effects of vit K on the cellular redox balance,
in contrast to the menadione-induced generation of
reactive oxygen species (Loor et al., 2010), vit K1 and K2
supplementation never induced oxidative stress. In particular,
vit K1 never modified the intracellular accumulation of
O2
 and H2O2 (data not shown), whereas vit K2, at the
highest dose (100mM), significantly (Pp0.05) reduced the level
Table 1. Plasma levels of selected ectopic calcification-
related parameters
Controls1 PXE
Calcium
mg dl 1
8.6–10.3 9.53±0.4
Phosphate
mg dl 1
2.4–4.8 3.4±0.6
ALP activity
U l1
40–129 66.5±37.7
dp-ucMGP
pmol l1
426±235 300±221
dp-cMGP
pmol l1
1,865±597 1,169±603
dp-ucMGP/dp-cMGP 0.23±0.09 0.24±0.12
Abbreviations: ALP, alkaline phosphatase; cMGP, carboxylated MGP; dp-
cMGP, dephospho carboxylated MGP; dp-ucMGP, dephospho uncarboxy-
lated MGP; MGP, matrix gla protein; PXE, pseudoxanthoma elasticum.
1Normal reference range or values.
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of O2
 in both control and PXE fibroblasts. In particular,
values measured as fluorescence arbitrary units were
0.70±0.07 in controls, 0.55±0.07 in controlsþK2, 1.11±
0.06 in PXE, and 0.66±0.07 in PXEþK2, in agreement with
previous observations that menaquinone can act as a positive
modulator of oxidative stress (Li et al., 2009).
ER proteins involved in vit K cycle
To exclude that vit K supplementation may be associated with
ER stress, having a negative effect on vit K–dependent
carboxylation, and favoring the calcification process
(Liberman et al., 2011), we have investigated the expression
of GRP-78 (glucose-regulated ER stress response protein-78), a
well-known marker of ER stress (Zhang and Kaufman, 2006).
Data indicate that GRP-78 expression (Figure 2a and b)
was very similar in control and in PXE fibroblasts, and
remained unmodified after treatments, clearly demonstrating
that intracellular accumulation of vit K is not associated with
ER stress.
Moreover, as PXE fibroblasts are characterized by chronic
oxidative stress (Pasquali-Ronchetti et al., 2006) and the redox
environment within the ER is known to affect the carboxy-
lation process, we investigated whether vit K supplementation
can modify the expression of other molecules that, in the ER,
are involved in the vit K cycle, such as protein disulfide
isomerase (Figure 2a and c) and calumenin (Figure 2a and d),
which are downregulated and upregulated, respectively, in
PXE (Boraldi et al., 2009). Both vit K1 and K2, independently
from concentration, similarly downregulated the expression of
calumenin in all cell strains (Figure 2a and d), whereas
changes were negligible in the case of protein disulfide
isomerase (Figure 2a and c), indicating that the effect of vit
K supplementation on the expression of ER proteins involved
in the vit K cycle was not pathway-specific.
Protein carboxylation and MGP expression
Gamma carboxyglutamil residues were evaluated on total
protein extracts as markers of protein carboxylation. Data
reveal that control and PXE fibroblasts have a comparable
number of bands of similar intensity (Figure 3a and b),
suggesting that the whole carboxylation process in PXE
fibroblasts is equivalent to that of controls.
Possibly because of the low sensibility of this parameter,
low doses of vit K1 and K2 are not associated with significant
differences in total densitometry of bands. By contrast, high
doses of vit K1 and K2 markedly upregulated band intensity in
all cell strains, indicating that the carboxylation process is
similarly modulated in both control and PXE fibroblasts
(Figure 3a and b).
Moreover, by comparing data on the intracellular vit K
content (Figure 1) and the amount of carboxylated proteins
(Figure 3a and b), it appears that vit K2, although present
inside cells at lower levels compared with phylloquinone, has
a similar effect on the carboxylation process, in agreement
with previous findings that menaquinone is more efficient than
phylloquinone in extra-hepatic tissues (Wallin et al., 2008).
On the basis of the positive effects of vit K on the
carboxylation process, we have looked for changes in MGP
expression and maturation. Unexpectedly, vit K supplementa-
tion never induced a significant MGP upregulation. In parti-
cular, at high doses vit K1 significantly reduced MGP protein
expression in PXE fibroblasts (Figure 3f), whereas both in
control and PXE fibroblasts vit K2 downregulated MGP at gene
and protein levels (Figure 3c–f). Moreover, treatment with vit
K2, at all doses, did not increase cMGP (Figure 3g and h),
whereas vit K1 appeared to upregulate cMGP, although only
in control fibroblasts (Figure 3g).
All these data are in agreement and help understand the
observations by Brampton et al. (2011) that MGP remained
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Figure 1. Amount of vitamins K1 and K2 taken up by control and
pseudoxanthoma elasticum (PXE) dermal fibroblasts. Intracellular
determinations of phylloquinone (vitamin K1, a) and menaquinone (vitamin
K2, b) content in fibroblasts from control and PXE patients grown in vitro for
48 h after confluence in the presence of the vitamin (0.1, 1, 10, and 100mM).
As controls, cells were cultured in the presence of comparable amounts of
dimethylformamide (DMF) without vitamin K. A dose-dependent uptake can
be measured in both control and PXE cells (a linear regression analysis is
shown in small graphs in the upper-left side of each panel).
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undercarboxylated in the muzzle tissue of ABCC6  / mice,
despite the increase in circulating levels of vit K. In particular,
results from the present study demonstrate that in PXE, in a
general setting of vit K availability and adequate carboxylation
process, MGP is not sufficiently carboxylated. It could be
suggested that the defect may specifically involve MGP and
that the extent of gamma carboxylation could be related not
only on the bioavailability of cofactors, but also on the binding
affinity between proteins and gamma glutamylcarboxylase
(Berkner, 2008).
Surprisingly, in the absence of any effect on cell counts
and/or cell viability, K2 negatively modulated MGP expres-
sion, apparently in contradiction with the statement that
in vivo vit K2 is specifically active in modulating the
calcification process (Spronk et al., 2003; Beulens et al.,
2009), although in most cases positive effects, observed
either in vitro and/or in vivo, have to be related to
supplementation with menaquinones with longer chains or
by the simultaneous presence of other dietary components
and/or to healthier lifestyle behavior (Rees et al., 2010).
Moreover, it cannot be excluded that these results could be
because of a different behavior of fibroblasts compared with
smooth muscle cells or, such as those that have been
described in other cell types (Goritz et al., 2007; Mertsch
et al., 2009), with the association of low MGP expression
with low proliferation/migration of cells as an additional
effect of vit K2 supplementation.
ALP activity
ALP is considered a marker of calcification as it degrades
phosphate donors, releasing inorganic phosphate and decreas-
ing the concentration of inhibitors, such as pyrophosphate
(Orimo and Shimada, 2008). Evaluation of ALP activity in
fibroblasts cultured in standard medium clearly shows that
values are elevated in PXE fibroblasts and remain unmodified
by vit K, whereas a significant inhibition can be measured
after levamisole supplementation (Table 2).
Calcification assay
Independent from their ability to induce mineralization
in vivo, cells in normal culture conditions are not able to
mineralize because of the presence in the culture medium of
bovine serum factors, such as fetuin, which acts as a potent
calcification inhibitor. Therefore, to induce the calcification
process in vitro, a complex environment is necessary such as
that provided by addition of b-glycerophosphate (a source of
organic phosphate), dexamethasone (a glucocorticoid that
upregulates and downregulates osteogenic or inhibitor mole-
cules, respectively), and ascorbic acid (an essential cofactor
for collagen synthesis as a fundamental substrate for mineral
deposition) (Buranasinsup et al., 2006). Starting from 10 days
of culture in this specific calcifying medium, areas of
mineralization can be visualized in all fibroblast strains,
progressively increasing with time (Figure 4). The heteroge-
neous distribution of calcifications on the cell surface indi-
cates that this phenomenon is not a passive diffuse
precipitation, but it is the result of specific cell-dependent
processes. Treatment with levamisole inhibited the minerali-
zation process, whereas vit K supplementation was always
uneffective in all cell strains (Figure 4). The observation that
menaquinone, at the lowest concentration, actually favored
the accumulation of mineral deposits, could be because of the
fact that, as observed in osteoblastic cell lines, vit K2,
differently from vit K1, has a transcriptionally regulatory
function on extracellular matrix genes (Koshihara et al.,
2003; Ichikawa et al., 2006), consistent with the use of vit
K2 as a potential anti-osteoporotic agent (Iwamoto et al.,
2009.
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Figure 2. Effect of vitamins (Vit) K1 and K2 on the expression of endoplasmic
reticulum (ER)-related proteins in control and in pseudoxanthoma elasticum
(PXE) fibroblasts. (a) Representative western blot analysis of control (lines 1, 3,
5, 7, and 9) and PXE (lines 2, 4, 6, 8, and 10) fibroblasts in the presence of
dimethylformamide (DMF; lines 1 and 2), 0.1mM K1 (lines 3 and 4), 100mM K1
(lines 5 and 6), 0.1mM K2 (lines 7 and 8), and 100mM K2 (lines 9 and 10).
(b–d) Expression of GRP-78 (glucose-regulated ER stress response protein-78,
b), protein disulfide isomerase (PDI, c), and calumenin (CALU, d) evaluated
by western blot analysis on control (left panels) and PXE (right panels)
fibroblasts, cultured for 48 hours after confluence with vit K1 or K2
(0.1 and 100mM). Data in histograms are expressed as mean values±SD.
*Po0.05 treatment versus DMF (dotted line set at 1).
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Evaluation of ALP activity (Figure 4) in these long-term
culture conditions indicates that enzyme activity (1) is higher
in PXE compared with control fibroblasts; (2) is not signifi-
cantly modified by vit K supplementation; and (3) is influ-
enced by the extracellular environment, because of the
progressive accumulation of matrix molecules as in the case
of cells cultured in calcifying medium (CM). It is noteworthy
that CM favors extracellular matrix deposition (Figure 1 and
Supplementary Material online), leading to a thick layer of
matrix covering and partially embedding the cell monolayer;
and for this reason, at 30 days the matrix is so dense that it
negatively interferes with protein solubilization, unabling
appropriate ALP activity determination. Surprisingly, for long
periods of culture in CM (X20 days) the highest dose of vit K2
was associated with changes in cellular morphology, leading
to areas of cell detachment in both control and PXE fibroblasts
(Figure 4). However, it is worth mentioning that no toxic
effects were noticed on cells grown in standard medium
supplemented with vit K2 (at all doses and for long times of
culture; Figure 2 and Supplementary Material online), nor in
CM alone or in the presence of phylloquinone (data not
shown). Therefore, it could be hypothesized that menaqui-
none may interact with some CM component(s), thus nega-
tively interfering with cell viability.
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Figure 3. Effect of vitamins (Vit) K1 and K2 on carboxylated proteins in control and in pseudoxanthoma elasticum (PXE) fibroblasts. Determination of gamma
carboxyglutamil (Gla) residues (a, b) and matrix Gla protein (MGP) expression (c–h) in control and PXE confluent fibroblasts grown for 48 hours in DMEMþ 10%
fetal bovine serum (DM) supplemented with the solvent alone (dimethylformamide; DMF) or with vit K1 and vit K2 (0.1 and 100mM). Representative western blots
analysis for Gla residues are shown in panels a and b, whereas values on top of each line represent densitometric analyses of all bands obtained in duplicate using
all cell strains. The MGP expression was analyzed by reverse transcriptase–PCR (c, d) and western blot analysis (e, f), whereas carboxylated MGP (cMGP)
was evaluated by two-dimensional western blot analysis (g, h). Data are expressed as mean values±SD from all different cell lines assessed separately (a–f) or from
replicates using a pool of fibroblasts (g, h). *Po0.05 treatment vs. DMF (dotted line set at 1); yPo0.05 PXE vs. control fibroblast within the same experimental
condition; #Po0.05 PXE vs. control fibroblasts pool within the same experimental condition.
Table 2. ALP activity in control and PXE fibroblasts treated for 48hours after confluence
DMEMþ vitamin K1 DMEMþ vitamin K2
DMEMþ levamisole
DMEM 0.1lM 100lM 0.1lM 100lM 100lM
Control1 1±0.2 0.9±0,2 1.2±0.05 1±0.1 1±0.09 0.2±0.092
PXE1 1.5±0.33 1.3±0,1 1.1±0.2 1.1±0.3 1.1±0.2 0.1±0.072
Abbreviations: ALP, alkaline phosphatase; PXE, pseudoxanthoma elasticum.
1Enzyme activity is measured in confluent fibroblasts. Values are normalized to those of control fibroblasts cultured in DMEM, set as one-fold, and expressed as
mean values±SD.
2Pp0.01 Levamisole treatment versus DMEM.
3Pp0.05 PXE versus control fibroblasts.
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Conclusions
Despite the well-known limits provided by the simplifications
usually associated with in vitro models, nevertheless, studies
on cultured human dermal fibroblasts that, isolated from
healthy subjects as well as from PXE patient’s, maintain
in vitro several characteristics related to their pathologic
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Figure 4. In vitro calcification assay. Control and pseudoxanthoma elasticum (PXE) fibroblasts were cultured in standard medium (DMEM) or in calcifying
medium (CM) supplemented with vitamin K1, K2, or levamisole. Calcificaton is visualized at 30 days by light microscopy as dark precipitates (upper panels). In the
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different time points, together with alkaline phosphatase (ALP) activity (fold changes normalized to control fibroblasts cultured for 10 days in CM plus DMF). Data
are expressed as mean values±SD. #Occurrence of cellular morphological alterations; *Po0.05 PXE versus control. N.D. (not determined) because of areas of cell
death or of thickness and partial insolubility of the deposited extracellular matrix, in the case of mineralization and ALP activity, respectively.
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phenotype (Quaglino et al., 2011), allow direct investigation
of the response of human peripheral mesenchymal cells,
avoiding interferences caused by dietary absorption
properties and/or transport capabilities in the circulation.
From in vivo studies on the PXE animal model, it was
suggested that, because of still elusive mechanisms,
availability of vit K is not a limiting factor in the pathology
of PXE and/or that vit K–dependent inhibition of calcification
may not be preponderant in the development of the disease
(Brampton et al., 2011). Present results demonstrate that vit K1
and K2 can be taken up and accumulated at similar levels by
control and PXE fibroblasts, and that the carboxylation process
can be consequently similarly upregulated in both cell strains,
although MGP cannot be adequately carboxylated, even at
increased levels of vit K. Therefore, it can be excluded that
PXE fibroblasts are not capable to utilize the vitamin, thus
suggesting that altered MGP characteristics/properties could at
least contribute to defective carboxylation.
Within this context and given its peculiar matrix localization
on the elastic component (Gheduzzi et al., 2007), MGP may
contribute to the selective mineral deposition on elastic fibers.
Moreover, the observation that in an in vitro calcification
model, both vit K1 and K2 are ineffective in inhibiting the
mineralization process, also in controlling fibroblasts, i.e, in
cells that do not exhibit reduced cMGP, may underline the
importance and the complexity of the extracellular
environment in mineral deposit formation and in regulating
cell behavior. In the development of ectopic calcifications, not
a single component is prevalent or unique, but the unbalanced
ratio between many different factors locally controlling calcium
and phosphate homeostasis, as well as the characteristics of the
extracellular matrix, may be decisive in the question whether a
tissue will start to calcify. Therefore, in addition to vit K–
dependent molecules, other factors, including the upregulation
of ALP, must be taken into account for future therapeutic options.
MATERIALS AND METHODS
More detailed information on materials and methods is available at
Supplementary Materials and Methods online.
Patients
PXE patients were diagnosed on the basis of clinical manifestations,
histopathological findings, and identification of ABCC6 gene muta-
tions (Gheduzzi et al., 2004).
Laboratory parameters (calcemia, phosphatemia, and ALP activity)
were measured in the plasma of 79 patients, according to the Clinical
Pathology Laboratory routine procedures.
Plasma levels of dephospho ucMGP and dephospho cMGP were
measured in the same patients by sandwich ELISA techniques, already
developed at VitaK BV (Maastricht, The Netherlands) (Cranenburg
et al., 2010). The different sensitivity of the two antibodies does not
allow a direct comparison of the amount of two forms of MGP, and
evaluations have to be carried out between controls and PXE within
the same parameter.
Cells and treatments
Human dermal fibroblast cultures, in accordance with the Declara-
tion of Helsinki protocol and the guidelines of the ethical committee
of the Modena University Faculty of Medicine after written informed
consent, were obtained from five clinically healthy females (38±7
years), who did not exhibit any sign of genetic, metabolic, or
connective tissue disorders, and from six PXE patients (40±10 years).
Confluent fibroblasts were treated with 0.1, 1, 10, and 100mM
phylloquinone (vit K1; Sigma, St Louis, MO) or menaquinone (MK-4;
vit K2; Sigma) or with 100mM levamisole (Sigma). Cells grown in the
presence of dimethylformamide (Sigma) alone were used as control of
treatments.
Unless otherwise specified, cells from each individual were kept
separate during all experiments.
Fibroblast’s morphology was evaluated by phase-contrast micro-
scopy, and cell viability was assessed by cell count.
HPLC chromatography
Confluent fibroblasts were treated with vitamins for 48 hours, washed
in buffer, trypsinized, and centrifuged. Cell pellets were stored
at  80 1C and sent to VitaK for measuring on cell extracts, vit K1
and K2 intracellular concentrations by HPLC, using a reversed-phase
column with online zinc reduction and fluorescence detection
(Schurgers et al., 2007).
Flow cytometry
Intracellular levels of O2
 and H2O2 were estimated by FACS after
incubation of fibroblasts with 1mM DH2 or with 2mM H2DCF-DA
(Molecular Probes, Eugene, OR), respectively (Boraldi et al., 2009).
Experiments were conducted three times in duplicate.
Protein extraction and western blot
Cells were homogenized in RIPA buffer with protease inhibitors
(Sigma), centrifuged, and supernatants collected and stored
at  80 1C until analysis. After measurement of protein concentration
(Bradford, 1976), proteins were separated by one- or two-dimensional
PAGE (Gheduzzi et al., 2007; Boraldi et al., 2009). After separation,
proteins were transferred to nitrocellulose and incubated with anti-
GRP-78, anti-protein disulfide isomerase (Abcam, Cambridge, UK);
anti-calumenin, anti-MGP (Santa Cruz Biotechnology, Santa Cruz,
CA); anti-gamma carboxyglutamil residues (American Diagnostica,
Stamford, CT); anti-cMGP (Vascular Products, Maastricht, The
Netherlands); and thereafter with appropriate horseradish
peroxidase–conjugated secondary antibodies (Abcam).
One-dimensional PAGE experiments were conducted at least two
times with all different cell lines. In case of cMGP, owing to the low
abundance of the protein, analyses by two-dimensional PAGE were
performed on proteins extracted from a pool of fibroblasts from six
patients and from five controls, and data are expressed as mean
values±SD of replicates.
Quantitative real-time reverse transcriptase–PCR
Total RNA was isolated from cells using the RNeasy Protect cells Mini
kit (Qiagen, Milano, Italy) and reversely transcribed using Superscript
III (Invitrogen, Monza, Italy) and Oligo dT18 primers (Invitrogen).
Complementary DNAs were amplified on an iCycler (BioRad,
Hercules, CA) using SYBR GreenER qPCR SuperMix (Invitrogen).
The MGP gene expression in each sample was normalized against
CLK2 and quantified (Pfaffl, 2001). Experiments were conducted two
times in triplicate.
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ALP activity
ALP activity was measured spectrophotometrically at 405 nm on
control and PXE fibroblasts, and values of optical density were related
to cellular protein concentration (Bradford, 1976). Experiments were
conducted three times in triplicate.
In vitro calcification and von Kossa staining
Fibroblasts were routinely cultured in six-well plates (BD-Falcon,
Franklin Lakes, NJ) up to confluence, then the standard medium
(DMEMþ 10% fetal bovine serum, Gibco, Monza, Italy) was
replaced by the same medium or by the CM (i.e., standard medium
plus 10 mM b-glycerophosphate, 50mg ml 1 ascorbic acid and
10 nM dexamethasone, Sigma; Buranasinsup et al., 2006). Vit K1
and K2 (0.1 and 100mM, respectively) and levamisole (100mM) were
added to each type of culture media. After 10–20–30 days, cells
were stained with the von Kossa method, and areas of mineralization
were quantified on digital images. Experiments were conducted
three times.
Data analysis
Data are expressed as mean values±SD of all measurements and
compared using Mann–Whitney test or analysis of variance test using
GraphPad software (San Diego, CA).
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